Literature DB >> 18433756

Impaired endothelial function in C-reactive protein overexpressing mice.

Hwee Teoh1, Adrian Quan, Fina Lovren, Guilin Wang, Sam Tirgari, Paul E Szmitko, Alexander J Szalai, Michael E Ward, Subodh Verma.   

Abstract

Increasing evidence suggests that the inflammatory biomarker, C-reactive protein (CRP), may play a causal role in the development and progression of atherothrombosis. Since endothelial dysfunction is an early and integral component of atherosclerosis, we hypothesized that endothelial homeostasis would be impaired in CRP-overexpressing CRP transgenic (CRPtg) mice. Male CRPtg and wild-type mice were injected thrice over 2 weeks with vehicle or turpentine to induce the inflammation-sensitive CRP transgene. Serum human CRP levels in turpentine-treated CRPtg mice was 276.28 +/- 95.7 microg/ml. Human CRP was undetectable in the sera of wild-type mice and present at only low levels (1.41 +/- 0.2 microg/ml) in vehicle-treated CRPtg mice (n=6-8 mice/group). Aortic segments from turpentine-induced CRP-overexpressing CRPtg mice demonstrated impaired endothelium-dependent responses to acetylcholine vs. those from vehicle-treated CRPtg controls (57.1 +/- 9.5% vs. 85.0 +/- 5.0%, P<0.05, n=6). Nitric oxide release as well as phosphorylated eNOS protein expression from isolated aortic segments of CRPtg mice overexpressing CRP were markedly reduced compared to that from vehicle-treated controls. Masson's trichrome staining revealed increased perivascular fibrosis in CRP-overexpressing CRPtg mice. CRP overexpression was also associated with augmented aortic endothelial staining for VCAM-1 and MCP-1 and enhanced macrophage infiltration. Mice overexpressing the human CRP gene exhibit endothelial dysfunction, possibly via reduced NO bioavailability, with resultant changes in vascular structure. These data further support a role for CRP in mediating endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433756     DOI: 10.1016/j.atherosclerosis.2008.02.034

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  24 in total

1.  Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.

Authors:  Nathan C Sundgren; Weifei Zhu; Ivan S Yuhanna; Ken L Chambliss; Mohamed Ahmed; Keiji Tanigaki; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2011-09-22       Impact factor: 17.367

2.  Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients.

Authors:  Raffaele Maio; Angela Sciacqua; Rosamaria Bruni; Alessandra Pascale; Giuseppe Carullo; Paola E Scarpino; Desirée Addesi; Ines Spinelli; Giulia Galiano Leone; Francesco Perticone
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

3.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

4.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

5.  Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome.

Authors:  Michal Pravenec; Takashi Kajiya; Václav Zídek; Vladimír Landa; Petr Mlejnek; Miroslava Simáková; Jan Silhavý; Hana Malínská; Olena Oliyarnyk; Ludmila Kazdová; Jianglin Fan; Jiaming Wang; Theodore W Kurtz
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

Review 6.  Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Authors:  Sridevi Devaraj; Simona Valleggi; David Siegel; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

7.  C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction.

Authors:  Sridevi Devaraj; Jung-Mi Yun; Grete Adamson; Jose Galvez; Ishwarlal Jialal
Journal:  Cardiovasc Res       Date:  2009-07-20       Impact factor: 10.787

Review 8.  The evolving role of C-reactive protein in atherothrombosis.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

9.  Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance.

Authors:  Ishwarlal Jialal; Subodh Verma; Sridevi Devaraj
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

10.  Diurnal variability of C-reactive protein in obstructive sleep apnea.

Authors:  Paul J Mills; Loki Natarajan; Roland von Känel; Sonia Ancoli-Israel; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2009-06-17       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.